For the fourth consecutive year, we partnered with Parkwalk to analyse equity investments in UK spinouts. Together, we investigated the sources of funding and the recipient companies, shedding light on this vital aspect of the business landscape—and brought you our new report, Equity Investment into Spinouts 2023.
What is Parkwalk?
Parkwalk oversees a portfolio of investments in top-tier university spin-outs, specialising in ‘hard science’ companies that commercialise scientific breakthroughs from the UK’s globally-ranked research universities.
As the UK’s most active investor in the university spin-out sector, Parkwalk manages over £450m in assets. The company has invested in more than 160 companies through its managed funds, including collaborations with renowned institutions such as the universities of Oxford, Cambridge, Imperial, and Bristol.
What is a spinout?
An academic spinout, also known as a university spin-off or university spin-out, refers to a company founded based on intellectual property or research developed within an academic institution such as a university, research institute, or laboratory.
These spinouts are typically established by researchers, faculty members, or students who wish to commercialise innovative ideas, technologies, or products from academic research.
Find out more: Spotlight on Spinouts 2023.






